H1 nets $6 mln from Shore Group
Summary
New York, NY – October 30, 2018 – H1, the first company to arm healthcare organizations with live data insights to help fight diseases, announced today that Shore Group has invested $6M to accelerate H1’s growth.H1 has built a technology infrastructure grounded in machine intelligence that enables it to quickly find and surface relevant data from any public clinical and scholarly database anywhere in the world.Incubated at Shore Group, over the past year, H1 grew swiftly, signing well over seven figures in revenue across some of the largest biopharma companies.H1 DaVinci (launched Sept 2018): Strategy-as-a-service offering that helps strategic planning team unlock more valuable opportunities, faster.Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, experts, scholarly content, markets, competitors and new opportunities through research grounded in actual data and clinical findings.